U.S. Healthtech Stock News

Onto Innovation recently took part in a KeyBanc virtual meeting on 9 December, where management outlined its current strategic initiatives and market outlook in semiconductor process control metrology and defect inspection. This engagement drew attention to the company’s balance-sheet strength and consistent revenue growth, reinforcing interest in how its high-performance inspection systems fit into broader semiconductor trends. Next, we'll explore how Onto Innovation’s KeyBanc discussion of...

Many investors are asking whether Carlyle Group at around $60 is still a smart buy or if most of the upside is already reflected in the price, and that is exactly what we are going to unpack here. The stock has climbed 6.9% over the last week, 11.7% over the past month, and is now up 18.6% year to date, adding to an increase of 123.1% over three years and 126.2% over five years. Recent headlines have focused on Carlyle sharpening its emphasis on core private equity, credit, and...

Nextpower (NXT) just put some fresh weight behind its growth story by opening a new Remote Monitoring Center in Nashville and teaming up with MSS Steel Tubes to double its Southeast steel fabrication capacity. See our latest analysis for Nextpower. That expansion story is landing in a market that has already been warming up to Nextpower, with the latest share price at $93.43 after a 1 day share price return of 4.52 percent and a powerful year to date share price return of 136.53 percent. The...

Huntington Ingalls Industries (HII) has quietly pushed to a fresh high, with the stock up about 19% over the past 3 months and roughly 74% year to date, drawing renewed attention from defense investors. See our latest analysis for Huntington Ingalls Industries. That surge sits on top of an already strong run, with the latest share price at $326.72 and solid defense spending tailwinds helping deliver a powerful year to date share price return and a hefty multi year total shareholder return...

Old National Bancorp recently announced that longtime Commercial Banking CEO Jim Sandgren will retire in April 2026, marking the end of a nearly 35-year career during which he helped shape the bank into a US$71.00 billion regional institution across 10 states. His retirement underscores an upcoming leadership transition in a core business line at a time when Old National’s commercial strategy and community engagement remain central to its identity. We’ll now examine how the Fed’s latest rate...

Chewy (CHWY) just posted its Q3 2026 numbers, with revenue of about $3.1 billion and net income of $59.2 million translating into basic EPS of roughly $0.14 as investors parse how the pet retailer is holding up in a tougher consumer backdrop. The company has seen quarterly revenue move from $2.88 billion in Q3 2025 to around $3.1 billion across 2026 so far, while basic EPS shifted from $0.01 a year ago to roughly the mid-$0.14 range in each quarter, setting up this print as a test of how...

In recent weeks, State Street Investment Management and Galaxy Asset Management launched plans for the State Street Galaxy Onchain Liquidity Sweep Fund (SWEEP), backed by US$200 million in seed capital from Ondo Finance, while ETF inflows surpassed US$1.25 billion this year, supported by active fixed-income strategies. Together, these developments highlight how State Street is pairing new tokenized cash-management solutions with strong ETF demand to reinforce its core asset-servicing and...

In early December 2025, WisdomTree, Inc. launched the WisdomTree Equity Premium Income Digital Fund, a tokenized product tracking the Volos U.S. Large Cap Target 2.5% PutWrite Index and available via its WisdomTree Prime and WisdomTree Connect platforms. This launch comes as WisdomTree reports record assets under management of US$139.00 billion and strong net inflows, underscoring its push to blend income-focused equity strategies with blockchain-based fund structures. We’ll now examine how...

Fresh rig count data from Baker Hughes (BKR) show North American activity ticking higher, with more U.S. oil rigs coming online just as 2025 output forecasts improve, putting the stock squarely back on investors’ radar. See our latest analysis for Baker Hughes. The uptick in rig activity comes after a choppier stretch for the stock, with a recent pullback leaving Baker Hughes at around $47.46. Its year to date share price return remains solid, and its multi year total shareholder return shows...

In November 2025, Viking Therapeutics reported that it had finished enrollment ahead of schedule in its Phase 3 VANQUISH-1 obesity trial, while also advancing its obesity candidate VK2735 into Phase 3 after earlier Phase 2 results. At the same time, unusually large options activity and split bullish-bearish positioning by major traders highlighted how closely investors are watching Viking’s obesity program progress. Next, we’ll examine how early completion of VANQUISH-1 enrollment shapes...

NovoCure (NVCR) just made a meaningful leadership shift, with CEO and director Ashley Cordova stepping down and long time insider Frank Leonard stepping up to the top job, a move investors will be parsing carefully. See our latest analysis for NovoCure. The leadership shake up lands as the share price, now at $13.66, has bounced with a 7 day share price return of 16.16 percent. It still carries a bruising 1 year total shareholder return of around negative 55 percent, signaling improving short...

Fulton Financial (FULT) has quietly put up a solid run lately, with the stock gaining about 5% this week and roughly 12% over the past month, outpacing many regional bank peers. See our latest analysis for Fulton Financial. Zooming out, that recent strength sits on top of a more measured backdrop. The share price is now at $19.96, with a modest year to date share price return but a solid five year total shareholder return that signals momentum has been building over the long haul. If Fulton’s...

Amazon.com (AMZN) is leaning hard into its next growth engine, committing $35 billion to India through 2030 to build out AI capabilities, logistics, and exports in what it sees as a long runway market. See our latest analysis for Amazon.com. Even with the latest share price at $230.28 and a relatively modest year to date share price return of 4.57%, the three year total shareholder return of 160.35% shows investors are still backing Amazon’s long term AI and cloud story, even if momentum has...

Broadridge Financial Solutions (BR) has been quietly reshaping its fintech toolkit, from migrating its Shareholder Disclosure Hub to Amazon Web Services to partnering with Xceptor and naming a new head of strategy for its broker dealer arm. See our latest analysis for Broadridge Financial Solutions. The latest fintech upgrades and strategy hires come as Broadridge’s $231.5 share price reflects a mixed picture, with a modestly positive year to date share price return and a much stronger three...

If you are wondering whether Atlassian is a bargain or a value trap at today’s price, you are not alone. This breakdown is designed to help you decide with greater confidence. The stock has bounced about 4.3% over the last week and 3.6% in the past month, but it is still down roughly 32.6% year to date and 41.5% over the last year. That combination often signals either deep value or lingering risk. Those moves have come as investors weigh Atlassian’s ongoing push to scale its cloud platform...

While Groupon, Inc. ( NASDAQ:GRPN ) shareholders are probably generally happy, the stock hasn't had particularly good...

Over the past year, insiders sold US$424k worth of Rigel Pharmaceuticals, Inc. ( NASDAQ:RIGL ) stock at an average...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Patrick Industries recently appeared in Mairs & Power Small Cap Fund’s third-quarter 2025 investor letter as a new holding, and earlier this month presented at the Raymond James TMT & Consumer Conference in New York, underscoring its profile across recreational vehicle, marine, manufactured housing, and residential construction markets. The fund’s decision to initiate a position after tariff and inventory concerns had pressured the stock highlights how some institutional investors view...

ICF International (ICFI) has been grinding through a mixed stretch in the market, and that uneven share performance is nudging investors to revisit whether the current valuation still makes sense. See our latest analysis for ICF International. Over the past few months, ICF International’s share price has tried to claw back ground, with a 1 month share price return of 11.12 percent partially offsetting a weaker year to date share price return of 24.44 percent and a 1 year total shareholder...

Pinnacle Financial Partners (PNFP) has quietly outperformed many regional peers, with the stock up about 6% this week and roughly 16% over the past month, drawing fresh attention to its valuation. See our latest analysis for Pinnacle Financial Partners. Zooming out, that short burst of strength comes after a tougher stretch, with the share price still showing a negative year to date share price return, while the five year total shareholder return near 70% hints at longer term compounding and...

CVS Health (CVS) just reset the bar for its turnaround, lifting its 2025 and 2026 guidance and laying out mid teens earnings growth targets through 2028 while unveiling an AI native consumer engagement platform. See our latest analysis for CVS Health. The updated guidance and AI platform plans have clearly caught investors’ attention. CVS Health’s 1 day share price return of 2.36% adds to an 82.79% year to date share price return and a 70% 1 year total shareholder return, suggesting momentum...

Palantir Technologies (PLTR) keeps drawing attention as its share price continues to swing after a huge run this year, prompting investors to revisit what is actually driving the story at current levels. See our latest analysis for Palantir Technologies. After a blistering run this year, Palantir’s latest share price of $187.54 reflects a market that is pausing to reassess expectations. This comes even as its year to date share price return of 149.42 percent and three year total shareholder...

Earlier this month, BrightSpring Health Services presented at the Bank of America Home Care Conference, where CEO Jon B. Rousseau and CFO Jennifer A. Phipps outlined the company’s home- and community-based care platform to investors. Shortly afterward, William Blair initiated research coverage on BrightSpring with a positive rating, signaling increased institutional attention and interest in the company’s long-term business outlook. Now, we’ll examine how William Blair’s new coverage and...